M. Courbebaisse and J. Souberbielle, Équilibre phosphocalcique : régulation et explorations, EMC, pp.18-28, 2010.
DOI : 10.1016/j.nephro.2010.12.004

S. Roux and P. Orcel, Équilibre phosphocalcique : régulation et exploration, Endocrinologie-Nutrition, pp.10-358, 1998.

F. Schmitt, Phosphates plasmatiques, Biologie médicale, pp.90-100, 2003.
DOI : 10.1016/S2211-9698(06)76107-6

P. Marie, P. Halbout, . Opg, and . Rankl, Implication et cible thérapeutique dans l'ostéoporose, Med Sci, vol.24, pp.105-114, 2008.

N. Giuliani, R. Bataille, C. Mancini, M. Lazzaretti, and S. Barille, Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment, Blood, vol.98, issue.13, pp.98-3527, 2001.
DOI : 10.1182/blood.V98.13.3527

L. Cavalli, C. Mazzotta, and M. Brandi, Phosphatonins : physiological role and pathological changes. Clin Cases Miner Bone Metab, pp.9-12, 2012.

C. Silve and L. Beck, Is FGF23 the long sought after phosphaturic factor phosphatonin? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association -European Renal Association, pp.958-61, 2002.

L. Quarles, Evidence for a bone-kidney axis regulating phosphate homeostasis, Journal of Clinical Investigation, vol.112, issue.5, pp.642-648, 2003.
DOI : 10.1172/JCI200319687

T. Larsson, R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren et al., Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the ??1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate Homeostasis, Endocrinology, vol.145, issue.7, pp.3087-94, 2004.
DOI : 10.1210/en.2003-1768

S. Liu, R. Guo, L. Simpson, Z. Xiao, C. Burnham et al., Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX, Journal of Biological Chemistry, vol.355, issue.39, pp.37419-37445, 2003.
DOI : 10.1210/en.143.8.3179

M. Riminucci, M. Collins, N. Fedarko, N. Cherman, A. Corsi et al., FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting, Journal of Clinical Investigation, vol.112, issue.5, pp.683-92, 2003.
DOI : 10.1172/JCI18399

M. Fukagawa and J. Kazama, With or without the kidney: the role of FGF23 in CKD, Nephrology Dialysis Transplantation, vol.20, issue.7
DOI : 10.1172/JCI106517

H. Saito, A. Maeda, S. Ohtomo, M. Hirata, K. Kusano et al., Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo

H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi et al., Regulation of Fibroblast Growth Factor-23 Signaling by Klotho, Journal of Biological Chemistry, vol.285, issue.10, pp.2816120-2816123, 2006.
DOI : 10.1016/j.cmet.2005.09.001

S. Ferrari, J. Bonjour, and R. Rizzoli, Fibroblast Growth Factor-23 Relationship to Dietary Phosphate and Renal Phosphate Handling in Healthy Young Men, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.3, pp.1519-1543, 2005.
DOI : 10.1210/jc.2004-1039

J. Stubbs, S. Liu, and L. Quarles, PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Role of Fibroblast Growth Factor 23 in Phosphate Homeostasis and Pathogenesis of Disordered Mineral Metabolism in Chronic Kidney Disease, Seminars in Dialysis, vol.14, issue.4, pp.302-310, 2007.
DOI : 10.1172/JCI200419081

L. Quarles and . Fgf23, FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization, American Journal of Physiology-Endocrinology and Metabolism, vol.285, issue.1, pp.1-9, 2003.
DOI : 10.1210/jc.2002-021105

J. Bacchetta, P. Cochat, and I. Salusky, [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism] FGF23 et Klotho : les nouveaux incontournables du metabolisme phosphocalcique, pp.18686-95, 2011.

S. Liu, L. Vierthaler, W. Tang, J. Zhou, and L. Quarles, FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23, Journal of the American Society of Nephrology, vol.19, issue.12, pp.2342-50, 2008.
DOI : 10.1681/ASN.2007121301

M. Razzaque and B. Lanske, The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis, Journal of Endocrinology, vol.194, issue.1, pp.1-10, 2007.
DOI : 10.1677/JOE-07-0095

L. Quarles, Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease, Experimental Cell Research, vol.318, issue.9, pp.1040-1048, 2012.
DOI : 10.1016/j.yexcr.2012.02.027

T. Krajisnik, P. Bjorklund, R. Marsell, O. Ljunggren, G. Akerstrom et al., Fibroblast growth factor-23 regulates parathyroid hormone and 1??-hydroxylase expression in cultured bovine parathyroid cells, Journal of Endocrinology, vol.195, issue.1, pp.125-156, 2007.
DOI : 10.1677/JOE-07-0267

U. Torres, P. Friedlander, G. De-vernejoul, M. Silve, C. Prie et al., Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients, Kidney International, vol.73, issue.1, pp.102-109, 2008.
DOI : 10.1038/sj.ki.5002622

P. Bonnichon, L. Charbit, and C. Proye, History of surgery of the parathyroid glands

J. Potts, Parathyroid hormone: past and present, Journal of Endocrinology, vol.187, issue.3, pp.311-336, 2005.
DOI : 10.1677/joe.1.06057

URL : http://joe.endocrinology-journals.org/content/187/3/311.full.pdf

B. Zabel, H. Kronenberg, G. Bell, and T. Shows, Chromosome mapping of genes on the short arm of human chromosome 11: parathyroid hormone gene is at 11p15 together with the genes for insulin, c-Harvey-ras 1, and β-hemoglobin, Cytogenetic and Genome Research, vol.39, issue.3, pp.39200-39205, 1985.
DOI : 10.1159/000132135

H. Keutmann, M. Sauer, G. Hendy, L. O-'riordan, J. Potts et al., Complete amino acid sequence of human parathyroid hormone, Biochemistry, vol.17, issue.26, pp.5723-5732, 1978.
DOI : 10.1021/bi00619a019

J. Vieira, . Pth, and . Assays, Understanding What We Have and Forecasting What We Will Have, Journal of osteoporosis, p.5, 2012.

J. Habener, M. Amherdt, M. Ravazzola, and L. Orci, Parathyroid hormone biosynthesis. Correlation of conversion of biosynthetic precursors with intracellular protein migration as determined by electron microscope autoradiography, The Journal of Cell Biology, vol.80, issue.3, pp.80715-80746, 1979.
DOI : 10.1083/jcb.80.3.715

P. Jr, J. Harald, and J. , Chapter 3 -Parathyroid Hormone and Parathyroid Hormone-Related Peptide in Calcium Homeostasis, Bone Metabolism, and Bone Development: The Proteins, Their Genes, and Receptors, Metabolic Bone Disease and Clinically Related Disorders, pp.51-94, 1998.

J. Habener, M. Rosenblatt, and J. Potts-jr, Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism., Physiological Reviews, vol.64, issue.3, pp.985-1053, 1984.
DOI : 10.1152/physrev.1984.64.3.985

J. Silver, J. Russell, and L. Sherwood, Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells., Proceedings of the National Academy of Sciences, vol.82, issue.12, pp.4270-4273, 1985.
DOI : 10.1073/pnas.82.12.4270

R. Kilav, J. Silver, and T. Naveh-many, -Acting Element in the Parathyroid Hormone 3???-Untranslated Region Is Sufficient for Regulation of RNA Stability by Calcium and Phosphate, Journal of Biological Chemistry, vol.3, issue.12, pp.8727-8760, 2001.
DOI : 10.1016/0092-8674(93)90046-S

F. Faivre-defrance, S. Marcelli-tourvieille, M. Odou, N. Porchet, J. Wemeau et al., Le r??cepteur sensible au calcium : physiologie et pathologie, Annales d'Endocrinologie, vol.67, issue.1, pp.45-53, 2006.
DOI : 10.1016/S0003-4266(06)72540-9

D. Riccardi and D. Martin, The Role of the Calcium-Sensing Receptor in the Pathophysiology of Secondary Hyperparathyroidism, Clinical Kidney Journal, vol.20, issue.10, pp.7-11, 2008.
DOI : 10.1097/01.ASN.0000141016.20133.33

R. Kumar and J. Thompson, The Regulation of Parathyroid Hormone Secretion and Synthesis, Journal of the American Society of Nephrology, vol.22, issue.2, pp.216-240, 2011.
DOI : 10.1681/ASN.2010020186

J. Souberbielle, E. Lawson-body, and C. Cormier, Actualité sur la PTH : nos dosages ne reconnaissent pas que la PTH intacte ! Immuno-analyse & Biologie spécialisée, pp.48-53, 2002.
DOI : 10.1016/s0923-2532(02)01166-3

J. Guéris, R??le physiologique et quantification de la parathormone humaine dans les liquides biologiques : difficult??s m??thodologiques et interpr??tation, Immuno-analyse & Biologie Sp??cialis??e, vol.8, issue.6, pp.339-386, 1993.
DOI : 10.1016/S0923-2532(05)80124-3

D. Amour and P. , Acute and chronic regulation of circulating PTH: Significance in health and in disease, Clinical biochemistry, p.6, 2012.

O. Bernard-poenaru, J. Guéris, and . Parathormone, Immuno-analyse & Biologie spécialisée, pp.24-31, 1996.

M. Rodriguez and V. Lorenzo, Parathyroid Hormone, A Uremic Toxin, Seminars in Dialysis, vol.139, issue.4, pp.363-371, 2009.
DOI : 10.1111/j.1525-139X.2009.00581.x

C. Massart and J. Souberbielle, Actualit??s sur les dosages de parathormone??: des difficult??s analytiques ?? l???interpr??tation des r??sultats en clinique, M??decine Nucl??aire, vol.33, issue.1, pp.46-52, 2009.
DOI : 10.1016/j.mednuc.2008.10.010

W. Goodman, H. Juppner, I. Salusky, and D. Sherrard, Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy, Kidney International, vol.63, issue.1, pp.631-642, 2003.
DOI : 10.1046/j.1523-1755.2003.00700.x

J. Souberbielle, Parathormone (PTH) EMC, pp.90-100, 2003.
DOI : 10.1016/s2211-9698(06)76101-5

C. Massart and A. Gauchez, Caractéristiques immuno-analytiques de la parathormone (PTH) Immuno-analyse & Biologie spécialisée, pp.79-82
DOI : 10.1016/j.immbio.2011.09.005

E. Cavalier, J. Souberbielle, and P. Delanaye, Suivi biologique du métabolisme phosphocalcique chez le patient dialysé : que nous apportent les guidelines du KDIGO en pratique ? Immuno-analyse & Biologie spécialisée, p.3, 2012.

E. Cavalier, A. Carlisi, A. Bekaert, O. Rousselle, J. Chapelle et al., New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay, Clinica Chimica Acta, vol.413, issue.1-2, pp.353-357, 2012.
DOI : 10.1016/j.cca.2011.09.034

G. Coen, E. Bonucci, P. Ballanti, A. Balducci, S. Calabria et al., PTH 1-84 and PTH ???7-84??? in the noninvasive diagnosis of renal bone disease, American Journal of Kidney Diseases, vol.40, issue.2, pp.348-54, 2002.
DOI : 10.1053/ajkd.2002.34519

I. Salusky, W. Goodman, B. Kuizon, J. Lavigne, R. Zahranik et al., Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis, Kidney International, vol.63, issue.5, pp.1801-1809, 2003.
DOI : 10.1046/j.1523-1755.2003.00915.x

G. Lehmann, G. Stein, M. Huller, R. Schemer, K. Ramakrishnan et al., Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry, Kidney International, vol.68, issue.3, pp.681206-681220, 2005.
DOI : 10.1111/j.1523-1755.2005.00513.x

H. Yamashita, P. Gao, S. Noguchi, T. Cantor, S. Uchino et al., Role of Cyclase Activating Parathyroid Hormone (1-84 PTH) Measurements During Parathyroid Surgery, Annals of Surgery, vol.236, issue.1, pp.105-116, 2002.
DOI : 10.1097/00000658-200207000-00016

R. Eastell, A. Arnold, M. Brandi, E. Brown, P. D-'amour et al., Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.2, pp.94340-50, 2009.
DOI : 10.1210/jc.2008-1758

E. Cavalier, A. Daly, D. Betea, P. Pruteanu-apetrii, P. Delanaye et al., The ratio of parathyroid hormone as measured by third-and secondgeneration assays as a marker for parathyroid carcinoma, The Journal of clinical endocrinology and metabolism, issue.8, pp.953745-953754, 2010.

D. Talancé, N. Claudon, A. Pesenti, M. Burlet, and C. , Dosage de la parathormone 1-84. Influence des conditions de prélèvement et de stockage. Immuno-analyse & Biologie spécialisée, pp.17118-17138, 2002.

D. Joly, T. Drueke, C. Alberti, P. Houillier, E. Lawson-body et al., Variation in Serum and Plasma PTH Levels in Second-Generation Assays in Hemodialysis Patients: A Cross-sectional Study, American Journal of Kidney Diseases, vol.51, issue.6, pp.51987-95, 2008.
DOI : 10.1053/j.ajkd.2008.01.017

X. Parent, F. Alenabi, P. Brignon, and J. Souberbielle, Conservation du tube primaire sur le site de dialyse en vue du dosage diff??r?? de la PTH??: quels tubes??? Quelle temp??rature???, N??phrologie & Th??rapeutique, vol.5, issue.1, pp.34-40, 2009.
DOI : 10.1016/j.nephro.2008.04.006

D. Holmes, A. Levin, B. Forer, and F. Rosenberg, Preanalytical Influences on DPC IMMULITE 2000 Intact PTH Assays of Plasma and Serum from Dialysis Patients, Clinical Chemistry, vol.51, issue.5, pp.915-922, 2005.
DOI : 10.1373/clinchem.2004.046821

H. Omar, A. Chamberlin, V. Walker, and P. Wood, Immulite 2000 Parathyroid Hormone Assay: Stability of Parathyroid Hormone in EDTA Blood Kept at Room Temperature for 48 h, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.38, issue.5, pp.561-564, 2001.
DOI : 10.1177/000456320103800516

P. Glendenning, L. Laffer, H. Weber, A. Musk, and S. Vasikaran, Parathyroid hormone is more stable in EDTA plasma than in serum, Clinical chemistry, vol.48, issue.5, pp.766-773, 2002.

P. Twomey, T. Whitlock, and D. Pledger, Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice, Journal of Clinical Pathology, vol.58, issue.9, pp.1000-1001, 2005.
DOI : 10.1136/jcp.2004.022186

J. Souberbielle, G. Friedlander, and C. Cormier, Aspects pratiques des dosages de PTH. Immuno-analyse & Biologie spécialisée, pp.110-118, 2006.
DOI : 10.1016/j.immbio.2006.01.001

W. Ratcliffe, D. Heath, M. Ryan, and S. Jones, Performance and diagnostic application of a two-site immunoradiometric assay for parathyrin in serum, Clinical chemistry, vol.35, issue.9, pp.1957-61, 1989.

P. Gao, S. Scheibel, P. D-'amour, M. John, S. Rao et al., Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1-84: Implications for Improvement of Accurate Assessment of Parathyroid Function, Journal of Bone and Mineral Research, vol.136, issue.4, pp.16605-16619, 2001.
DOI : 10.1016/S0085-2538(15)47156-X

J. Souberbielle, C. Cormier, C. Kindermans, P. Gao, T. Cantor et al., Vitamin D Status and Redefining Serum Parathyroid Hormone Reference Range in the Elderly, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.7, pp.863086-90, 2001.
DOI : 10.1210/jc.86.7.3086

J. Zanelli and R. Gaines-das, The First International Reference Preparation of Human Parathyroid Hormone for Immunoassay: Characterization and Calibration by International Collaborative Study, The Journal of Clinical Endocrinology & Metabolism, vol.57, issue.3, pp.57462-57471, 1983.
DOI : 10.1210/jcem-57-3-462

. Afssaps, Rapport du contrôle du marche Afssaps 2007-2008 des dispositifs médicaux de diagnostic in vitro de dosage de la parathormone (PTH). Immunoanalyse & Biologie spécialisée, pp.223-256, 2009.

J. Souberbielle, G. Friedlander, and C. Cormier, Practical considerations in PTH testing, Clinica Chimica Acta, vol.366, issue.1-2, pp.81-90, 2006.
DOI : 10.1016/j.cca.2005.10.010

S. Berson, R. Yalow, G. Aurbach, and J. Potts, IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE, Proceedings of the National Academy of Sciences of the United States of America, pp.49613-49620, 1963.
DOI : 10.1073/pnas.49.5.613

H. Komaba, S. Goto, and M. Fukagawa, Critical issues of PTH assays in CKD, Bone, vol.44, issue.4, pp.666-70, 2009.
DOI : 10.1016/j.bone.2008.12.016

C. Arnaud, H. Tsao, and T. Littledike, Radioimmunoassay of human parathyroid hormone in serum, Journal of Clinical Investigation, vol.50, issue.1, pp.21-34, 1971.
DOI : 10.1172/JCI106476

S. Rodgers and J. Lew, The Parathyroid Hormone Assay, Endocrine Practice, vol.17, issue.Supplement 1, pp.2-6, 2011.
DOI : 10.4158/EP10297.RA

S. Nussbaum, R. Zahradnik, J. Lavigne, G. Brennan, K. Nozawa-ung et al., Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia, Clinical chemistry, issue.8, pp.331364-331371, 1987.

L. Quarles, B. Lobaugh, and G. Murphy, Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia, The Journal of clinical endocrinology and metabolism, vol.75, issue.1, pp.145-50, 1992.

M. Wang, G. Hercz, D. Sherrard, N. Maloney, G. Segre et al., Relationship between intact 1???84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity, American Journal of Kidney Diseases, vol.26, issue.5, pp.836-880, 1995.
DOI : 10.1016/0272-6386(95)90453-0

J. Brossard, M. Cloutier, L. Roy, R. Lepage, M. Gascon-barre et al., Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values, The Journal of clinical endocrinology and metabolism, issue.11, pp.813923-813932, 1996.

R. Lepage, L. Roy, J. Brossard, L. Rousseau, C. Dorais et al., A non- (1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples, Clinical chemistry, vol.44, issue.4, pp.805-814, 1998.

D. 'amour, P. Brossard, J. Rousseau, L. Nguyen-yamamoto, L. Nassif et al., Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism, Kidney international, issue.3, pp.68998-1007, 2005.

M. John, W. Goodman, P. Gao, T. Cantor, I. Salusky et al., A novel immunoradiometric assay detects full-length human PTH but not aminoterminally truncated fragments: implications for PTH measurements in renal failure, The Journal of clinical endocrinology and metabolism, issue.11, pp.844287-90, 1999.

S. Nakanishi, J. Kazama, T. Shigematsu, Y. Iwasaki, T. Cantor et al., Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients, American Journal of Kidney Diseases, vol.38, issue.4, pp.172-176, 2001.
DOI : 10.1053/ajkd.2001.27436

M. Taniguchi, M. Tanaka, T. Hamano, S. Nakanishi, H. Fujii et al., Comparison between Whole and Intact Parathyroid Hormone Assays, Therapeutic Apheresis and Dialysis, vol.18, issue.3, pp.42-51, 2011.
DOI : 10.1046/j.1523-1755.2003.00262.x

J. Brossard, R. Lepage, H. Cardinal, L. Roy, L. Rousseau et al., Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays, Clinical chemistry, issue.5, pp.46697-703, 2000.

E. Cavalier, A. Carlisi, A. Bekaert, O. Rousselle, J. Chapelle et al., New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay, Clinica Chimica Acta, vol.413, issue.1-2, pp.353-357, 2012.
DOI : 10.1016/j.cca.2011.09.034

C. Giroud, M. Dumontet, A. Vassault, F. Braconnier, and G. Ferard, Groupe de travail SFBC. [Recommendations for expressing uncertainty of measurement of quantitative results in laboratory medicine], Annales de biologie clinique, vol.65, issue.2, pp.185-200, 2007.

X. Parent, F. Alenabi, E. Etienne, P. Brignon, F. Chantrel et al., Preanalytical variability of parathyroid hormone measurement in dialysis patients; application to Elecsys 2010 (Roche) automate], Annales de biologie clinique, vol.66, issue.1, pp.53-61, 2008.

M. Migliardi and D. Marranca, Mesure de la parathormone : facteurs de variation et problèmes de standardisation. Immuno-analyse & Biologie spécialisée, pp.119-145, 2006.

I. Bipm, . Ifcc, . Ilac, . Iupac, . Iupap et al., The international vocabulary of metrology?basic and general concepts and associated terms (VIM), JCGM, vol.200, 2012.

E. Cavalier, O. Rousselle, and A. Bekaert, Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH, Clinical Chemistry, pp.56-62, 2010.

E. Cavalier, J. Krzesinski, and P. Delanaye, Measurement of PTH in haemodialysis patients with a second or third generation kit: impact for the clinician, 2010.

P. Delanaye, J. Krzesinski, and E. Cavalier, Suivi ?? court et ?? long terme de la concentration de parathormone chez le patient h??modialys????: dosage de seconde et troisi??me g??n??ration, N??phrologie & Th??rapeutique, vol.7, issue.5, p.320, 2011.
DOI : 10.1016/j.nephro.2011.07.128

URL : http://orbi.ulg.ac.be/bitstream/2268/99945/1/suivi.pdf

J. Nizou, D. Brunengo, and A. Ebel, ??valuation du dosage de la PTH 1???84??de troisi??me g??n??ration sur automate Liaison?? Diasorin compar?? au dosage de la PTH intacte sur automate Modular?? Roche sur une population de dialys??s, Immuno-analyse & Biologie Sp??cialis??e, vol.26, issue.2
DOI : 10.1016/j.immbio.2011.03.032

J. Souberbielle, P. Boudou, and C. Cormier, Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism, Journal of Endocrinological Investigation, vol.236, issue.suppl1, pp.463-472, 2008.
DOI : 10.1097/00000658-200207000-00016

M. Marangella, PTH measurement: where do we stand, G Ital Nefrol, vol.26, issue.5, pp.600-607, 2009.

J. Herberth, A. Branscum, H. Mawad, T. Cantor, M. Monier-faugere et al., Intact PTH Combined With the PTH Ratio for Diagnosis of Bone Turnover in Dialysis Patients: A Diagnostic Test Study, American Journal of Kidney Diseases, vol.55, issue.5, pp.897-906, 2010.
DOI : 10.1053/j.ajkd.2009.12.041

J. Aloia, M. Feuerman, and J. Yeh, REFERENCE RANGE FOR SERUM PARATHYROID HORMONE, Endocrine Practice, vol.12, issue.2, pp.137-181, 2006.
DOI : 10.4158/EP.12.2.137

L. Rejnmark, P. Vestergaard, L. Heickendorff, and L. Mosekilde, Determinants of plasma PTH and their implication for defining a reference interval, Clinical Endocrinology, vol.146, issue.1, pp.37-43, 2011.
DOI : 10.4158/EP.12.2.137

J. Souberbielle, A. Boutten, M. Carlier, D. Chevenne, G. Coumaros et al., Inter-method variability in PTH measurement: Implication for the care of CKD patients, Kidney International, vol.70, issue.2, pp.70345-50, 2006.
DOI : 10.1038/sj.ki.5001606

C. Fillee, T. Keller, M. Mourad, T. Brinkmann, and J. Ketelslegers, Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions, Clinical Endocrinology, vol.94, issue.6, pp.785-794, 2012.
DOI : 10.1210/jc.2008-1760

T. Lepoutre, P. Nguyen, and M. Jadoul, Circulating levels of PTH 1-84 in renal transplant recipients, 2011.